View in EDS

147 A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN).

Saved in:
Bibliographic Details
Title: 147 A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN).
Authors: Burnett, A.1 (AUTHOR), El Rassi, F.2 (AUTHOR), Darbari, D.3 (AUTHOR), Paulose, J.4 (AUTHOR), Lainé, D.4 (AUTHOR), Purkayastha, D.5 (AUTHOR), Kato, G.6 (AUTHOR)
Source: Journal of Sexual Medicine. 2020 Supplement 1, Vol. 17, pS43-S43. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 141630008
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 147 A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Burnett%2C+A%2E%22">Burnett, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El+Rassi%2C+F%2E%22">El Rassi, F.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Darbari%2C+D%2E%22">Darbari, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paulose%2C+J%2E%22">Paulose, J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lainé%2C+D%2E%22">Lainé, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Purkayastha%2C+D%2E%22">Purkayastha, D.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kato%2C+G%2E%22">Kato, G.</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Journal+of+Sexual+Medicine%22">Journal of Sexual Medicine</searchLink>. 2020 Supplement 1, Vol. 17, pS43-S43. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=141630008
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jsxm.2019.11.092
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S43
    Titles:
      – TitleFull: 147 A Prospective Phase II, Open-Label, Single-arm, Multicenter Study to Assess the Efficacy and Safety of SEG101 (Crizanlizumab) in Sickle Cell Disease Patients With Priapism (SPARTAN).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Burnett, A.
      – PersonEntity:
          Name:
            NameFull: El Rassi, F.
      – PersonEntity:
          Name:
            NameFull: Darbari, D.
      – PersonEntity:
          Name:
            NameFull: Paulose, J.
      – PersonEntity:
          Name:
            NameFull: Lainé, D.
      – PersonEntity:
          Name:
            NameFull: Purkayastha, D.
      – PersonEntity:
          Name:
            NameFull: Kato, G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 01
              Text: 2020 Supplement 1
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 17436095
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Journal of Sexual Medicine
              Type: main
ResultId 1